Pyridostigmine Bromide
NDC 58657-810, PYRIDOSTIGMINE BROMIDE, tablet, from Method Pharmaceuticals, LLC.
- Product NDC
- 58657-810
- Status
- Listed
- Labeler
- Method Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211181
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58657-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE30 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58657-810-21 | 58657081021 | 21 TABLET in 1 BOTTLE (58657-810-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e756717f-941b-42f2-ba3b-03798c005ae7NADAC price for package 58657081021
GET /v1/drugs/nadac/58657081021
Use it
Look up 58657-810 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58657-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58657-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.